No one shall place any false, exaggerated, or secret labelling or advertisement with respect to the names, manufacturing methods, quality, nutrition labelling, genetically modified foods, etc., and the indication of tracking and controlling food history, and no label or advertisement with respect to the nutritional value, raw materials, ingredients, and uses of foods or additives, which have efficacy in preventing and treating diseases or are likely to cause confusion with medicine or functional health foods.

Nevertheless, from November 16, 2015, the Defendant reported the communications sales business at the above location, and from February 2016, posted it on the Internet homepage (C) for the sale of “D” products from around February 2016, the Defendant served as follows: “The generation rate of cardiopulmonary urine diseases, rain, cancer, etc., such as chronic urine diseases, etc.; the ambropic extraction of the ambal leaf leaves considerably low; the ambropic content of which is 12 type of malicious cells, such as ambrogen cancer, died of ambla, ambla, etc.; the ambalthalty of the amblain in line with the content of the effect in the ambrogen cancer and ambla, which is in line with the content of the amblamer’s 6-day local marization, thereby facilitating the amblamination and improvement of the ambia, and facilitating the symptoms of am.

In addition to the phrase, “,” etc., false exaggerated or exaggerated advertisements were made as if they have efficacy and effect in the prevention and treatment of diseases.

2. Determination:

(a) Article 13(1) of the Food Sanitation Act provides that no person shall use any false, exaggerated, or negative labelling or advertising with respect to the name of food, etc., manufacturing method, quality or nutrition labelling, genetic materials, associations of food, etc., and the indication of tracking and control of food history, and no person shall use any exaggerated packaging for packages:

food or food additives;